Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?
出版年份 2018 全文链接
标题
Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 119, Issue 4, Pages 389-407
出版商
Springer Nature America, Inc
发表日期
2018-07-27
DOI
10.1038/s41416-018-0201-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Practice Patterns and Outcomes in Elderly Stage I Non–Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis
- (2018) Shraddha M. Dalwadi et al. Clinical Lung Cancer
- Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
- (2018) I.S. Bhattacharya et al. CLINICAL ONCOLOGY
- The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report
- (2018) Cynthia Aristei et al. EJSO
- Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST)
- (2018) Grace I. Patrice et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant breast radiotherapy: How to trade-off cost and effectiveness?
- (2018) Chris Monten et al. RADIOTHERAPY AND ONCOLOGY
- Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen
- (2018) Lauren Henke et al. RADIOTHERAPY AND ONCOLOGY
- Preoperative breast radiation therapy: Indications and perspectives
- (2017) S.V. Lightowlers et al. EUROPEAN JOURNAL OF CANCER
- Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
- (2017) W. James Morris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
- (2017) Charles N. Catton et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
- (2017) Stephen G. Chun et al. JOURNAL OF CLINICAL ONCOLOGY
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
- (2017) Charlotte E Coles et al. LANCET
- Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
- (2017) Robert Glynne-Jones et al. LANCET ONCOLOGY
- Clinical endpoints in trials of chemoradiation for patients with anal cancer
- (2017) Robert Glynne-Jones et al. LANCET ONCOLOGY
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
- (2017) Corinne Faivre-Finn et al. LANCET ONCOLOGY
- What is the optimal radiotherapy schedule for limited stage small cell lung cancer?
- (2017) Ben Slotman LUNG CANCER
- Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study
- (2017) Joan Prades et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial
- (2017) Conny Vrieling et al. JAMA Oncology
- R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology
- (2017) Helena M. Verkooijen et al. Frontiers in Oncology
- Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study
- (2016) S. Nilsson et al. ANNALS OF ONCOLOGY
- Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy
- (2016) Lisette M. Wiltink et al. Clinical Colorectal Cancer
- Science in Focus: Combining Radiotherapy with Inhibitors of the DNA Damage Response
- (2016) A.J. Chalmers CLINICAL ONCOLOGY
- The cost and burden of cancer in the European Union 1995–2014
- (2016) Bengt Jönsson et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
- (2016) W. Robert Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
- (2016) Abram Recht et al. JOURNAL OF CLINICAL ONCOLOGY
- DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
- (2016) Lise Bech Jellesmark Thorsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
- (2016) Paula Mulvenna et al. LANCET
- 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
- (2016) Vratislav Strnad et al. LANCET
- Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
- (2016) Shafak Aluwini et al. LANCET ONCOLOGY
- Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
- (2016) Luca Incrocci et al. LANCET ONCOLOGY
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
- (2016) David Dearnaley et al. LANCET ONCOLOGY
- Clinical development of new drug–radiotherapy combinations
- (2016) Ricky A. Sharma et al. Nature Reviews Clinical Oncology
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice
- (2016) K. Haslett et al. RADIOTHERAPY AND ONCOLOGY
- MRI-guided prostate adaptive radiotherapy – A systematic review
- (2016) A.J. McPartlin et al. RADIOTHERAPY AND ONCOLOGY
- SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
- (2016) Jan Nyman et al. RADIOTHERAPY AND ONCOLOGY
- Hypofractionated radiotherapy for localized prostate cancer
- (2016) Stefan Höcht et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status
- (2016) Corinne Faivre-Finn et al. BMJ Open
- Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer
- (2016) Nicholas D. James et al. JAMA Oncology
- Current clinical trials testing the combination of immunotherapy with radiotherapy
- (2016) Josephine Kang et al. Journal for ImmunoTherapy of Cancer
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
- (2015) Michael Goldstein et al. Annual Review of Medicine
- Bowel Function 14 Years After Preoperative Short-Course Radiotherapy and Total Mesorectal Excision for Rectal Cancer: Report of a Multicenter Randomized Trial
- (2015) Tina Yen-Ting Chen et al. Clinical Colorectal Cancer
- HERO (Health Economics in Radiation Oncology): A Pan-European Project on Radiotherapy Resources and Needs
- (2015) Y. Lievens et al. CLINICAL ONCOLOGY
- Defining Bowel Dose Volume Constraints for Bladder Radiotherapy Treatment Planning
- (2015) F. McDonald et al. CLINICAL ONCOLOGY
- Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy
- (2015) L.J. Forker et al. CLINICAL ONCOLOGY
- Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial
- (2015) Lorenzo Livi et al. EUROPEAN JOURNAL OF CANCER
- Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
- (2015) Yasushi Nagata et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
- (2015) Lisette M. Wiltink et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
- (2015) Malcolm D. Mason et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
- (2015) Ben J Slotman et al. LANCET
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
- (2015) Jeffrey D Bradley et al. LANCET ONCOLOGY
- Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
- (2015) Shafak Aluwini et al. LANCET ONCOLOGY
- Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
- (2015) Anna Wilkins et al. LANCET ONCOLOGY
- Expanding global access to radiotherapy
- (2015) Rifat Atun et al. LANCET ONCOLOGY
- Regional Nodal Irradiation in Early-Stage Breast Cancer
- (2015) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
- (2015) Philip M. Poortmans et al. NEW ENGLAND JOURNAL OF MEDICINE
- The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis
- (2015) Josep M. Borras et al. RADIOTHERAPY AND ONCOLOGY
- Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial
- (2014) R. Glynne-Jones et al. ANNALS OF ONCOLOGY
- Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Glynne-Jones et al. ANNALS OF ONCOLOGY
- Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer
- (2014) N Groom et al. BRITISH JOURNAL OF RADIOLOGY
- Health-related quality of life 14years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomised trial
- (2014) Lisette M. Wiltink et al. EUROPEAN JOURNAL OF CANCER
- Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer
- (2014) R.D. Timmerman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013
- (2014) Justin E. Bekelman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular Radiobiology: The State of the Art
- (2014) Amato J. Giaccia JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy for breast cancer, the TARGIT-A trial
- (2014) Joanne S Haviland et al. LANCET
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
- (2014) Mila Donker et al. LANCET ONCOLOGY
- Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
- (2014) Oliver Sartor et al. LANCET ONCOLOGY
- Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
- (2014) David P Dearnaley et al. LANCET ONCOLOGY
- Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey
- (2014) Yolande Lievens et al. RADIOTHERAPY AND ONCOLOGY
- Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey
- (2014) Cai Grau et al. RADIOTHERAPY AND ONCOLOGY
- Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study
- (2013) Lise B. J. Thorsen et al. ACTA ONCOLOGICA
- Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review
- (2013) Jean-Emmanuel Bibault et al. CANCER AND METASTASIS REVIEWS
- Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial
- (2013) Leonard L. Gunderson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)
- (2013) Robert A. Huddart et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Global health 2035: a world converging within a generation
- (2013) Dean T Jamison et al. LANCET
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
- (2013) Jayant S Vaidya et al. LANCET
- Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
- (2013) Umberto Veronesi et al. LANCET ONCOLOGY
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
- (2013) Joanne S Haviland et al. LANCET ONCOLOGY
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
- (2013) Roger D James et al. LANCET ONCOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; Systematic review and comparison with a surgical cohort
- (2013) Francesca Soldà et al. RADIOTHERAPY AND ONCOLOGY
- RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
- (2012) Lisa A. Kachnic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
- (2012) Samuel Y. Ngan et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
- (2012) Leonard L. Gunderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
- (2012) Didier Peiffert et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in radiotherapy
- (2012) S. S. Ahmad et al. BMJ-British Medical Journal
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
- (2011) Willem van Gijn et al. LANCET ONCOLOGY
- Evaluation of implanted gold seeds for breast radiotherapy planning and on treatment verification: A feasibility study on behalf of the IMPORT trialists
- (2011) Charlotte E. Coles et al. RADIOTHERAPY AND ONCOLOGY
- Hypofractionated breast radiotherapy: Financial and economic consequences
- (2010) Yolande Lievens BREAST
- Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial
- (2010) M. Kusters et al. EJSO
- Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline
- (2010) Benjamin D. Smith et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117
- (2010) Jeffrey D. Bradley et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
- (2010) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Short-Course Preoperative Radiotherapy for Rectal Cancer on Patients' Quality of Life: Data From the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 Randomized Clinical Trial
- (2010) Richard J. Stephens et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
- (2010) David Palma et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11
- (2010) Edgar Ben-Josef et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials
- (2010) Penelope Hopwood et al. LANCET ONCOLOGY
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- (2010) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study
- (2010) Csaba Polgár et al. RADIOTHERAPY AND ONCOLOGY
- Risk factors for sexual dysfunction after rectal cancer treatment
- (2009) M.M. Lange et al. EUROPEAN JOURNAL OF CANCER
- Characterization of Target Volume Changes During Breast Radiotherapy Using Implanted Fiducial Markers and Portal Imaging
- (2009) Emma J. Harris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
- (2009) Achilles J. Fakiris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity-Modulated Radiotherapy–Based Stereotactic Body Radiotherapy for Medically Inoperable Early-Stage Lung Cancer: Excellent Local Control
- (2009) Gregory M.M. Videtic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
- (2009) Mark S. Roh et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
- (2009) Pia Baumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
- (2009) Phil Quirke et al. LANCET
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
- (2009) David Sebag-Montefiore et al. LANCET
- Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial
- (2009) Cécile Le Péchoux et al. LANCET ONCOLOGY
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
- (2009) Umberto Ricardi et al. LUNG CANCER
- Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
- (2008) D. D. Ruysscher et al. ANNALS OF ONCOLOGY
- Urinary dysfunction after rectal cancer treatment is mainly caused by surgery
- (2008) M. M. Lange et al. BRITISH JOURNAL OF SURGERY
- Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery – Audit on behalf of the IMPORT Trial Management Group
- (2008) C.E. Coles et al. EJSO
- EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer
- (2008) Rob Glynne-Jones et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal
- (2008) Jaffer A. Ajani JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105
- (2008) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups
- (2008) Berend J. Slotman et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
- (2008) Anders Widmark et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search